Paper27322425
Molecular driver alterations and their clinical relevance in cancer of unknown primary site.
Löffler H and 10 others. Oncotarget, 2016. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Molecular driver alterations and their clinical relevance in cancer of unknown primary site. Papers, record 27322425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27322425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular driver alterations and their clinical relevance in cancer of unknown primary site.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms, Unknown Primary | Major topic |
| Cyclin-Dependent Kinase Inhibitor p16 | |
| Cyclin-Dependent Kinase Inhibitor p18 | |
| DNA Mutational Analysis | |
| Female | |
| High-Throughput Nucleotide Sequencing | |
| Humans | |
| Male | |
| Middle Aged | |
| Molecular Targeted Therapy | |
| Mutation | |
| Proto-Oncogene Proteins p21(ras) | |
| Tumor Suppressor Protein p53 |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11902578 | Assessing TP53 status in human tumours to evaluate clinical outcome. | Nat Rev Cancer | 2001 | https://conductscience.org/library/papers/11902578 | PubMed |
| 2 | 26376137 | Acute Myeloid Leukemia. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26376137 | PubMed |
| 3 | 25323927 | Drugging the undruggable RAS: Mission possible? | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/25323927 | PubMed |
| 4 | 20697090 | TP53 mutation and survival in chronic lymphocytic leukemia. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20697090 | PubMed |
| 5 | 20551152 | The path to personalized medicine. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20551152 | PubMed |
| 6 | 17055429 | The regulation of INK4/ARF in cancer and aging. | Cell | 2006 | https://conductscience.org/library/papers/17055429 | PubMed |
| 7 | 8632491 | The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. | J Natl Cancer Inst | 1996 | https://conductscience.org/library/papers/8632491 | PubMed |
| 8 | 23973117 | Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. | J Mol Diagn | 2013 | https://conductscience.org/library/papers/23973117 | PubMed |
| 9 | 9927204 | Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. | Oncogene | 1999 | https://conductscience.org/library/papers/9927204 | PubMed |
| 10 | 3738291 | Censoring distributions as a measure of follow-up in survival analysis. | Stat Med | 1986 | https://conductscience.org/library/papers/3738291 | PubMed |
| 11 | 19692681 | Personalized medicine and inhibition of EGFR signaling in lung cancer. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19692681 | PubMed |
| 12 | 26182302 | Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies. | JAMA Oncol | 2015 | https://conductscience.org/library/papers/26182302 | PubMed |
| 13 | 12562643 | The unknown biology of the unknown primary tumour: a literature review. | Ann Oncol | 2003 | https://conductscience.org/library/papers/12562643 | PubMed |
| 14 | 25409386 | Carcinoma of unknown primary site. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25409386 | PubMed |
| 15 | 23480555 | Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks. | Eur J Clin Invest | 2013 | https://conductscience.org/library/papers/23480555 | PubMed |
| 16 | 26404825 | Somatic mutation in cancer and normal cells. | Science | 2015 | https://conductscience.org/library/papers/26404825 | PubMed |
| 17 | 7550353 | Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. | Nat Genet | 1995 | https://conductscience.org/library/papers/7550353 | PubMed |
| 18 | 11595686 | Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11595686 | PubMed |
| 19 | 19623297 | Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome. | Dtsch Arztebl Int | 2008 | https://conductscience.org/library/papers/19623297 | PubMed |
| 20 | 21388974 | BRAFV600E: implications for carcinogenesis and molecular therapy. | Mol Cancer Ther | 2011 | https://conductscience.org/library/papers/21388974 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42681672 | Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence era. | Biomark Res | 2026 | https://conductscience.org/library/papers/42681672 | PubMed |
| 42477427 | A prospective national precision medicine trial evaluating the feasibility of blood-based molecular profiling in patients with Cancer of Unknown Primary (CUP-COMP). | Br J Cancer | 2026 | https://conductscience.org/library/papers/42477427 | PubMed |
| 41806238 | SEOM-GECOD clinical guideline for cancer of unknown primary (update 2025). | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41806238 | PubMed |
| 41122443 | Epidemiologic, histopathological, and prognostic analysis of cancer of unknown primary in an Iranian population. | J Res Med Sci | 2025 | https://conductscience.org/library/papers/41122443 | PubMed |
| 39292320 | A machine learning-based method for feature reduction of methylation data for the classification of cancer tissue origin. | Int J Clin Oncol | 2024 | https://conductscience.org/library/papers/39292320 | PubMed |
| 38404120 | Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary. | Cancer Med | 2024 | https://conductscience.org/library/papers/38404120 | PubMed |
| 37875494 | Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. | Nat Commun | 2023 | https://conductscience.org/library/papers/37875494 | PubMed |
| 37519592 | Adenocarcinoma of an Unknown Primary Site: Presentation, Diagnosis, and Management. | Cureus | 2023 | https://conductscience.org/library/papers/37519592 | PubMed |
| 37359927 | Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review. | Indian J Surg Oncol | 2023 | https://conductscience.org/library/papers/37359927 | PubMed |
| 36722641 | Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/36722641 | PubMed |
| 36287571 | A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary. | J Pathol | 2023 | https://conductscience.org/library/papers/36287571 | PubMed |
| 35918329 | Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity. | Nat Commun | 2022 | https://conductscience.org/library/papers/35918329 | PubMed |
| 35320504 | SEOM-GECOD clinical guideline for unknown primary cancer (2021). | Clin Transl Oncol | 2022 | https://conductscience.org/library/papers/35320504 | PubMed |
| 34302033 | Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP). | Sci Rep | 2021 | https://conductscience.org/library/papers/34302033 | PubMed |
| 33516660 | Cancer of Unknown Primary in the Molecular Era. | Trends Cancer | 2021 | https://conductscience.org/library/papers/33516660 | PubMed |
| 33504059 | Cancer of Unknown Primary: Challenges and Progress in Clinical Management. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33504059 | PubMed |
| 32511869 | Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report. | EMBO Mol Med | 2020 | https://conductscience.org/library/papers/32511869 | PubMed |
| 32457826 | The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review. | Front Oncol | 2020 | https://conductscience.org/library/papers/32457826 | PubMed |
| 32350398 | Progress in refining the clinical management of cancer of unknown primary in the molecular era. | Nat Rev Clin Oncol | 2020 | https://conductscience.org/library/papers/32350398 | PubMed |
| 32010631 | "Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"? | Front Oncol | 2019 | https://conductscience.org/library/papers/32010631 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| SLTM | 79811 | PubTator's text mining | https://conductscience.org/library/genes/79811 | NCBI Gene |
| SMAD4 | 4089 | PubTator's text mining | https://conductscience.org/library/genes/4089 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27322425
GET https://conductscience.org/api/papers/v1/27322425/references?page=2